Company Overview and News


Add GRANULES
to your dashboard

Headline News

Granules India gets USFDA approval for Prasugrel tablet

2017-10-18 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.

Granules US partner gets ANDA approval for heart drug

2017-10-18 moneycontrol
Granules India today said the US Food and Drug Administration has approved its Abbreviated New Drug Application ((ANDA) filed by USpharma Windlas LLC for Prasugrel tablets, used for treatment of heart disease.

Granules India Limited - Updates

2017-10-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India Limited - Updates

2017-10-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India (₹140.6)

2017-10-16 premium.thehindubusinessline
Buying a house to just rent it out may not be a lucrative option in India, shows study of data provided by JLL India. Average rental yields were 3.1 per cent, as of May 2017, for top six cities in... »

Market Update: Nifty trims morning gains as Bank Nifty turns negative; BPCL up 2%, Godrej Agrovet most active

2017-10-16 moneycontrol
Both Nifty and the Sensex trimmed their respective morning gains after both indices hit record highs in morning trade. The fall was largely aided by Reliance Industries which was down 0.68 percent. IndusInd Bank was the top Nifty loser down over 2 percent as the market did not take its merger with Bharat Financial Inclusion in a positive way. (44-0)

Market Update: Nifty clings above 10K as midcaps shine; Bharti Airtel top gainer, Britannia hits 1-yr high

2017-10-12 moneycontrol
Indian markets opened a positive note on Thursday with the Nifty opening up 29 points at 10,013.80 and the Sensex gaining 60.51 points at 31,894.50. The midcap index was the outperforming sector in the early hours of trade led by Biocon, Bharat Financial Inclusion, JSW Energy and Hindustan Zinc. (11-0)

Closing Bell: Sensex ends flat, while Nifty closes below 10,000; midcaps underperform

2017-10-09 moneycontrol
3:30 pm Market Check: Equity benchmark began the week on a flat note, with the Nifty ending below 10,000-mark. (12-0)

Granules India gains 4% as Motilal Oswal expects over 50% return on strong financials

2017-10-09 moneycontrol
Granules India share price rallied nearly 4 percent intraday Monday as Motilal Oswal believes the stock has the potential to deliver more than 50 percent return in the next 12-18 months on the back of multiple re rating and strong EPS CAGR of around 30 percent till FY20.

Pharma Newsletter October 02 to October 06, 2017

2017-10-07 indiainfoline
This week, “Granules India informed that the USFDA has issued Establishment Inspection Report (EIR) for the Granules OmniChem facility, a 50:50 JV between the company and Ajinimoto OmniChem N.V. at Vizag, Andhra Pradesh.”

Morgan Stanley sells 17.67 lakh shares of Granules India

2017-10-07 moneycontrol
On October 6, 2017 Morgan Stanley (France) S.A. sold 17,67,051 shares of Granules India at Rs 119.37 on the NSE. (52-0)

Granules India gets EIR from USFDA for Vizag OmniChem facility

2017-10-06 moneycontrol
Drug firm Granules India today said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Vizag, Andhra Pradesh.

Granules India gets EIR from USFDA for Vizag OmniChem facility

2017-10-06 thehindubusinessline
Drug firm Granules India today said it has received an Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Vizag, Andhra Pradesh.

Granules India gains 4% on EIR from USFDA for Vizag facility

2017-10-06 moneycontrol
Shares of Granules India advanced 5 percent intraday Friday as it has received EIR from USFDA for its Vizag facility.

Granules India Limited - Updates

2017-10-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India Limited - Shareholders meeting

2017-09-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India Limited - Allotment of Securities

2017-09-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India's QIP issue open for sale at floor price of Rs 127.63

2017-09-21 business-standard
As a premium subscriber you get an across device unfettered access to a range of services which include:

Granules India Limited - Qualified Institutional Placement

2017-09-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India Limited - Committee Meeting Updates

2017-09-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Granules India Limited - Outcome of Board Meeting

2017-09-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Corporate Action ⠠RURAL ELECTRIFICATION CORPORATION, BALKRISHNA INDUSTRIES, GODREY PHILIPS, PETRONET LNG, INFIBEAM INCORPORATION, SUZLON ENERGY, ENGINEERS INDIA, JAIN IRRIGATION SYSTEM, UNITED BRE

2017-08-17 indiainfoline
Corporate Action – RURAL ELECTRIFICATION CORPORATION, BALKRISHNA INDUSTRIES, GODREY PHILIPS, PETRONET LNG, INFIBEAM INCORPORATION, SUZLON ENERGY, ENGINEERS INDIA, JAIN IRRIGATION SYSTEM, UNITED BRE

USFDA issues 'no observation' against Granules India

2017-08-16 indiainfoline
Shares of Granules India surged by over 8% intraday on Wednesday after the company informed that the USFDA has issued positive Establishment Inspection Report (EIR) for the Gagillapur facility of the company located at Hyderabad, Telangana, India.

USFDA issues inspection report for Granules India’s Gagillapur plant

2017-08-16 thehindubusinessline
Drug firm Granules India today said the US health regulator has issued an establishment inspection report for its Gagillapur plant in Hyderabad without any observations.

US FDA issues EIR for Granules India’s Gagillapur plant

2017-08-16 livemint
New Delhi: Drug firm Granules India on Wednesday said the US health regulator has issued establishment inspection report for its Gagillapur plant in Hyderabad without any observations.